Science Explorer Interactive view Map
Company · Burnaby · Canada

Inimex Pharmaceuticals (Canada)

Research works
95
▲ 96% vs 2013–17
Citations
6.8k
71.8 per fractional work
Top-10% rate
9.1%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: Inimex Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.21× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 2.93× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.11× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.75× its world share, 0 worksChemistryComputer Science: 0.56× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringHealth Professions: 0.82× its world share, 0 worksHealth ProfessionsMedicine: 1.52× its world share, 2 worksMedicineBusiness, Management and Accounting: 5.36× its world share, 1 worksBusiness, Management…Decision Sciences: 4.47× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 7.07× its world share, 1 worksEconomics, Econometr…Psychology: 0.35× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 7.1×. Every wedge is a field page.

Which keywords describe research at Inimex Pharmaceuticals (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, RNA Interference, siRNA Delivery, Nanoparticles, Cancer Therapy, Cancer, Membrane Proteins and Cholesterol.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy15▲ 59×5 topics
  2. RNA Interference11▲ 106×1 topic
  3. siRNA Delivery11▲ 158×1 topic
  4. Nanoparticles10▲ 7.6×8 topics
  5. Cancer7▲ 5.5×17 topics
  6. Cancer Therapy7▲ 11×9 topics
  7. Membrane Proteins6▲ 35×3 topics
  8. Inflammation6▲ 2.6×17 topics
  9. Cholesterol6▲ 32×3 topics
  10. Lipid Rafts5▲ 80×2 topics
  11. Cell Membranes5▲ 93×1 topic
  12. Membrane Lipids5▲ 93×1 topic
  13. Self-Assembly5▲ 14×4 topics
  14. Innate Immunity5▲ 15×6 topics
  15. Biosensors5▲ 8.8×2 topics
  16. Drug Delivery5▲ 10×5 topics
  17. DNA nanotechnology4▲ 46×1 topic
  18. aptamers4▲ 46×1 topic
  19. Biomedical Applications4▲ 4.3×5 topics
  20. Immunity4▲ 13×6 topics
  21. Tumor Targeting4▲ 33×3 topics
  22. Nanocarriers4▲ 90×1 topic
  23. Surface Engineering4▲ 34×1 topic
  24. Cancer Immunotherapy4▲ 27×2 topics
  25. Antigen Presentation3▲ 36×1 topic
  26. Dendritic Cells3▲ 31×1 topic
  27. Toll-like Receptors3▲ 19×2 topics
  28. AAV3▲ 49×1 topic
  29. Apoptosis3▲ 8.2×9 topics
  30. Viral Vectors3▲ 49×1 topic
  31. Neurotoxicity3▲ 17×4 topics
  32. Pattern Recognition Receptors3▲ 21×2 topics
  33. Cytokine-Mediated Link3▲ 42×1 topic
  34. Innate Antiviral Responses3▲ 42×1 topic
  35. Glycosylation2▲ 12×3 topics
  36. Chemotherapy-Induced Peripheral Neuropathy2▲ 51×1 topic
  37. Taxanes2▲ 51×1 topic
  38. NK Cell Recognition2▲ 24×1 topic
  39. Natural Killer Cells2▲ 24×1 topic
  40. Genomic Stability2▲ 24×2 topics

Which research topics does Inimex Pharmaceuticals (Canada) publish most on?

By volume in 2022–2025: Market Dynamics and Volatility, Law, logistics, and international trade, Cannabis and Cannabinoid Research and PARP inhibition in cancer therapy.

  1. 1 Market Dynamics and Volatility Economics and Econometrics 1 works
  2. 2 Law, logistics, and international trade Accounting 1 works
  3. 3 Cannabis and Cannabinoid Research Pharmacology 0 works
  4. 4 PARP inhibition in cancer therapy Oncology 0 works
  5. 5 FOXO transcription factor regulation Molecular Biology 0 works
  6. 6 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
  7. 7 Scientific Computing and Data Management Information Systems and Management 0 works
  8. 8 Signaling Pathways in Disease Molecular Biology 0 works
  9. 9 Big Data and Business Intelligence Management Information Systems 0 works
  10. 10 Cloud Computing and Resource Management Information Systems 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.6%not open76.4%

World: 28% of research is openly available.

with international co-authors21.2%domestic only78.8%

World: 19% is written across borders.

How has Inimex Pharmaceuticals (Canada)'s research output changed?

Output in 2018–2022 was 96% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Burnaby

All research institutions in Burnaby

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.